Skip to main content
Clinical Trials/NCT07424924
NCT07424924
Recruiting
Not Applicable

The Relationship Between Balance and Gait Impairments, Physical Activity Level, and Sleep Quality in Parkinson's Disease

Biruni University1 site in 1 country34 target enrollmentStarted: January 5, 2026Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
Biruni University
Enrollment
34
Locations
1
Primary Endpoint
Mini Balance Evaluation Systems Test (Mini-BESTest) Score

Overview

Brief Summary

This study aims to investigate the relationship between balance and gait impairments, physical activity levels, and sleep status in individuals with Parkinson's disease (PD). Both motor and non-motor symptoms of PD significantly affect quality of life, yet these dimensions are often evaluated separately. By examining gait, balance, physical activity, and sleep parameters together and comparing patients with healthy individuals of similar age, the study seeks to clarify how these variables interact and whether observed impairments are disease-specific or related to natural aging. The findings are expected to contribute to a more comprehensive understanding of PD and support the development of more effective management strategies.

Detailed Description

This study will be conducted between January 2026 and May 2026 and will include 34 participants aged 45-70 years: 17 individuals diagnosed with Parkinson's disease and 17 age-matched healthy individuals without neurodegenerative disease. Participants will be recruited from Biruni University Hospital and Biruni University. Gait analysis will be performed using Kinovea software by recording a 3-meter walk in the sagittal plane, allowing evaluation of parameters such as step length and arm swing. Physical activity will be assessed using a 2-Minute Walk Test monitored with a pulse oximeter to measure oxygen saturation and functional exercise capacity, as well as daily step counts recorded over one week using a wearable smart band (Honor Choice Band). Balance will be evaluated using the Mini-BESTest. Sleep status will be assessed objectively through the smart band, which records deep sleep, light sleep, REM sleep, and wakefulness, and subjectively using the Pittsburgh Sleep Quality Index. Participants will install the Wear Sync application on their smartphones to enable synchronization and collection of wearable device data.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
40 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • For Patients with Parkinson's Disease:
  • A confirmed diagnosis of Parkinson's disease according to the United Kingdom (UK) Brain Bank Criteria and classified as Hoehn and Yahr stages 1-3
  • Ability to walk independently on a flat surface without assistive devices (Functional Ambulation Scale ≥3)
  • Stable medication regimen during the past month
  • Being in the "on" phase of medication
  • For Healthy Individuals:
  • No diagnosis of neurological and/or neurodegenerative disease

Exclusion Criteria

  • (For both Parkinson's patients and healthy individuals)
  • Severe hearing or visual impairments
  • Presence of other neurological, cardiovascular, or orthopedic conditions that may affect walking ability
  • Any additional neurological disorder (e.g., dementia, cerebrovascular disease)
  • Education level less than 5 years
  • Vascular pathologies affecting the lower extremities
  • Lack of smartphone use

Arms & Interventions

Healthy Volunteers

Age-matched healthy individuals (45-70 years) without neurological or chronic diseases. Participants will undergo gait analysis (Kinovea), Mini-BESTest for balance assessment, 2-Minute Walk Test with pulse oximeter monitoring, one-week physical activity monitoring via wearable device (Honor Choice Band), and sleep evaluation using wearable-recorded sleep parameters and the Pittsburgh Sleep Quality Index.

People with Parkinson's Disease

Individuals aged 45-70 years diagnosed with Parkinson's disease. Participants will undergo gait analysis (Kinovea), Mini-BESTest for balance assessment, 2-Minute Walk Test with pulse oximeter monitoring, one-week physical activity monitoring via wearable device (Honor Choice Band), and sleep evaluation using wearable-recorded sleep parameters and the Pittsburgh Sleep Quality Index.

Outcomes

Primary Outcomes

Mini Balance Evaluation Systems Test (Mini-BESTest) Score

Time Frame: Baseline (single assessment during study participation)

Dynamic balance performance assessed using the Mini Balance Evaluation Systems Test (Mini-BESTest). The Mini-BESTest is a 14-item clinical balance assessment tool with scores ranging from 0 to 28, where higher scores indicate better balance performance. The test evaluates anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait.

Secondary Outcomes

  • Kinovea-Based Gait Parameters (Step Length and Stride Length)(Baseline (single assessment during study participation))
  • 2-Minute Walk Test (2MWT) Distance(Baseline (single assessment during study participation))
  • Daily Step Count (Wearable-Recorded Physical Activity)(7 days (during one-week monitoring period))
  • Pittsburgh Sleep Quality Index (PSQI) Total Score(Baseline (single assessment during study participation))
  • Wearable-Derived Sleep Parameters (Sleep Stages and Wake Time)(7 days (during one-week monitoring period))

Investigators

Sponsor
Biruni University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Guzin Kaya Aytutuldu

Assistant Professor

Biruni University

Study Sites (1)

Loading locations...

Similar Trials